Skip to main content

Marta Rebull Santamaria

Institutions of which they are part

Research technician
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Marta Rebull Santamaria

Institutions of which they are part

Research technician
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino

IP: Antonio Gil Moreno
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Marta Rebull Santamaria, Martina Angeles Fite, Ana Luzarraga Aznar, Melissa Bradbury Lobato, Beatriz Villafranca Magdalena, Melek Denizli , Lourdes Elena Salazar Huayna, Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino, Valeria Tubita
Funding agency: Instituto de Salud Carlos III
Funding: 196250
Reference: PI24/01509
Duration: 01/01/2025 - 31/12/2027

ScreenEC, validació d'una eina de triatge no invasiu en càncer d'endometri

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 99946
Reference: SLT036/24/000059
Duration: 21/12/2024 - 31/12/2026

Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melek Denizli , Lourdes Elena Salazar Huayna
Funding agency: Instituto de Salud Carlos III
Funding: 278300
Reference: DTS23/00091
Duration: 01/01/2024 - 31/12/2026

NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO.

IP: Antonio Gil Moreno
Collaborators: Silvia Cabrera Diaz, Marta Rebull Santamaria, Irene De la Calle Fuentes
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 369335
Reference: CPP2021-008440
Duration: 14/02/2022 - 30/09/2025

Ministerio de Ciencia

Related news

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

Related professionals

Sandra  Banderas García

Sandra Banderas García

Ophtalmology
Read more
Gaizka Loyola Sawmillan

Gaizka Loyola Sawmillan

Research technician
Clinical Neuroimmunology
Read more
Raquel Hladun Alvaro

Raquel Hladun Alvaro

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Sofia Alonso Mateos

Sofia Alonso Mateos

Research technician
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.